Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 17 | 7631360 | missense variant | C/A;T | snv | 5.6E-05; 4.5E-03 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 17 | 7631360 | missense variant | C/A;T | snv | 5.6E-05; 4.5E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 17 | 7631360 | missense variant | C/A;T | snv | 5.6E-05; 4.5E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 17 | 7631360 | missense variant | C/A;T | snv | 5.6E-05; 4.5E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
17 | 7633780 | downstream gene variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
17 | 7633780 | downstream gene variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
17 | 7629707 | intron variant | G/A | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
17 | 7629707 | intron variant | G/A | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
17 | 7628647 | intron variant | T/C | snv | 0.46 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
17 | 7628647 | intron variant | T/C | snv | 0.46 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.060 | 0.833 | 6 | 2004 | 2019 | ||||||
|
0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 0.833 | 6 | 2003 | 2012 | ||||||
|
0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 0.833 | 6 | 2003 | 2012 | ||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.030 | 0.667 | 3 | 2010 | 2014 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||||
|
0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||||
|
0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||||
|
0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 |
|
Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2011 | 2017 | ||||||
|
1.000 | 0.040 | 17 | 7630506 | missense variant | A/G | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||||||
|
17 | 7633255 | missense variant | A/G | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||||
|
1.000 | 0.040 | 17 | 7631341 | missense variant | G/A;C | snv | 2.8E-05; 1.7E-03 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 |